Search results
Treatment Options for HER2-Negative Breast Cancer
Healthline· 7 days agoMost breast cancers are HER2-negative. There are many treatment options for this type of breast cancer. Your treatment
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda By Reuters
Investing.com· 6 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 6 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 7 days agoOverall, 27.3% responded to the treatment. A total of 63.6% of patients had their disease under...
British patients test world’s first personalised mRNA jab for melanoma
PA Media: Science via Yahoo News· 5 days agoThe therapy combination is also being trialled in lung, bladder and kidney cancer. One of the first...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 6 days agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 5 days agoHospitals (UCLH) doctors are giving it alongside another drug, pembrolizumab or Keytruda, that also...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 6 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 7 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows ...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 22 hours agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...